OGTT Insulin Values for Diagnosing Insulin Resistance in PCOS
There are no universally standardized OGTT insulin cutoff values to definitively diagnose insulin resistance in PCOS, but the most practical approach uses fasting insulin >100 μIU/mL, glucose/insulin ratio <6 (for glucose in mg/dL) or <0.333 (for glucose in mmol/L), HOMA-IR >2, or insulin increase >100 μIU/mL during OGTT 1.
Diagnostic Approach
The challenge with insulin resistance diagnosis in PCOS is that fasting insulin levels alone are inadequate, particularly in normal-weight women with PCOS. Fasting insulin remains normal in a considerable proportion of PCOS patients, especially those with BMI <25, and does not predict the insulin response to glucose loading 1.
Recommended Insulin Resistance Markers
Use these criteria interchangeably based on clinical context 1:
- Elevated fasting insulin: >100 μIU/mL
- Decreased glucose/insulin ratio: <6 (when glucose measured in mg/dL) or <0.333 (when glucose measured in mmol/L)
- HOMA-IR index: >2
- Insulin response during OGTT: Increase >100 μIU/mL from baseline
Key Clinical Findings
More than two-thirds of PCOS women show abnormal insulin markers, including non-obese patients 1. The prevalence of abnormal insulin markers increases progressively with BMI:
- Normal weight (BMI <25): Substantial proportion still show insulin resistance
- Overweight (BMI 25-30): Higher rates of elevated fasting insulin
- Obese (BMI >30-35): Majority demonstrate insulin resistance
- Severely obese (BMI >35): Nearly universal insulin resistance 1
Critical Pitfall: Don't Rely on Fasting Glucose Alone
Fasting glucose levels detected abnormalities in only 2.2% of PCOS patients, while 2-hour OGTT glucose identified impaired glucose tolerance or diabetes in 8.5% 1. This represents a nearly 4-fold difference in detection rates, making the full OGTT essential for identifying glucose metabolism disorders in PCOS.
Clinical Context
Insulin resistance affects up to 80% of PCOS cases and is central to the pathophysiology, driving both hyperandrogenism and ovulatory dysfunction through selective insulin resistance where metabolic signaling is impaired but steroidogenic pathways remain active 2. The 2013 Endocrine Society guideline emphasizes that lifestyle modification is first-line therapy for insulin resistance in PCOS, with metformin reserved for cases where lifestyle changes fail, particularly for preventing progression to type 2 diabetes in those with impaired glucose tolerance 3.
Practical Algorithm
- Perform full OGTT with parallel glucose and insulin measurements at 0,60, and 120 minutes
- Calculate all four markers: fasting insulin, glucose/insulin ratio, HOMA-IR, and insulin increment
- Diagnose insulin resistance if any marker is abnormal
- Assess glucose tolerance using 2-hour glucose values (not just fasting)
- Stratify by BMI as insulin resistance severity correlates with obesity level
The information provided by glucose/insulin ratio, HOMA-IR, and insulin stimulation during OGTT is similar, allowing clinicians to use them alternatively based on laboratory availability and cost considerations 1.